Sinonasal Squamous Cell Carcinoma: Clinical Trials

3 trials for Sinonasal Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2
Phase 11Active not recruiting 1

Follow Sinonasal Squamous Cell Carcinoma: new trials by email Literature Review of Sinonasal Squamous Cell Carcinoma trials Research Report on Sinonasal Squamous Cell Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Biopsy Procedure, Biospecimen Collection, Carboplatin - Sinonasal Squamous Cell Carcinoma, Stage III Sinonasal Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)1082026-09-012026-10-05
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Toripalimab + Chemotherapy, Toripalimab, Chemoradiotherapy or radiation - Head and Neck Cancer, Squamous Cell Carcinoma
Phase 2RecruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins752026-02-182026-04-23
Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma
Biopsy Procedure, Birinapant, Computed Tomography - Locally Recurrent Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)132019-09-252026-08-03

Narrower conditions

Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)  ·  Papillomavirus Infections (1)

Broader conditions

Carcinoma (1)  ·  Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Infections (1)  ·  Laryngeal Diseases (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Squamous Cell (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)

Interventions

Biopsy (2)  ·  Carboplatin (2)  ·  Chemoradiotherapy (2)  ·  Cisplatin (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Radiation (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Docetaxel (1)  ·  Drug Therapy (1)  ·  Paclitaxel (1)  ·  Platinum (1)  ·  Radiotherapy (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Specimen Handling (1)  ·  Surgical Procedures, Operative (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (3)

Top investigators

Nyall R London, MD, Ph.D (1)  ·  Siddharth Sheth (1)  ·  Vassiliki Saloura (1)

NIH funding

UM1CA186712 (1)